Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: Results from a community-based clinic

Digestive Diseases and Sciences

Volumn 55, Issue 3, 2010, Pages 826-835

  Tong, Myron J ^a,b,c   Sun, Hai En ^a   Hsien, Carlos ^a   Lu, David S K ^c  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alpha fetoprotein; Asian Americans; Hepatitis B; Hepatocellular carcinoma; Surveillance; Ultrasound

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASIAN AMERICAN; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; TUMOR GROWTH; TUMOR VOLUME; ABDOMEN; COMMUNITY CARE; ECHOGRAPHY; LIVER FUNCTION TEST; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; UNITED STATES;

ABDOMEN; ALPHA-FETOPROTEINS; ASIAN AMERICANS; CARCINOMA, HEPATOCELLULAR; COMMUNITY HEALTH SERVICES; FEMALE; HEPATITIS B; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TUMOR BURDEN; UNITED STATES;

EID: 77949322576     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1059-y     Document Type: Article

References (43)

1. DM Parkin 2001 Global cancer statistics in the year 2000 Lancet Oncol 2 533 543 10.1016/S1470-2045(01)00486-7 1:STN:280:DC%2BD387ntlCrtw%3D%3D 11905707 (Pubitemid 33586866)
2. HB El-Serag LK Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557 2576 10.1053/j.gastro.2007. 04.061 1:CAS:528:DC%2BD2sXnvFOgsrw%3D 17570226 (Pubitemid 46890874)
3. KH Han JK Kim 2007 Liver cancer in Korea Hepatol Res 37 2 S106 S109 10.1111/j.1872-034X.2007.00171.x 17877469
4. JG Chen DM Parkin QG Chen, et al. 2003 Screening for liver cancer: results of a randomized controlled trial in Qidong, China J Med Screen 10 204 209 10.1258/096914103771773320 14738659 (Pubitemid 38091209)
5. I Ikai S Arii M Okazaki, et al. 2007 Report of the 17th nationwide follow-up survey of primary liver cancer in Japan Hepatol Res 37 676 691 10.1111/j.1872-034X.2007.00119.x 17617112 (Pubitemid 47054774)
6. Y Barazani JR Hiatt MJ Tong, et al. 2007 Chronic viral hepatitis and hepatocellular carcinoma World J Surg 31 1243 1248 10.1007/s00268-007-9041-3 17440771 (Pubitemid 47029929)
7. Tong MJ, Chavalitdhamrong D, Lu DSK, et al. Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA. J Clin Gastroenterol. 2009 (in press).
8. AM Di Biscelglie AC Lyra M Schwartz, et al. 2003 Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status Am J Gastroenterol 98 9 2060 2063 (Pubitemid 37185806)
9. SF Alterkruse KA McGlynn ME Reichman 2009 Hepatocellular carcinoma incidence, morality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 9 1485 1491 10.1200/JCO.2008.20.7753
10. M McCracken M Olsen MS Chen Jr, et al. 2007 Cancer incidence, mortality and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean and Japanese ethnicities CA Cancer J Clin 57 190 205 10.3322/canjclin.57.4.190 17626117 (Pubitemid 47312080)
11. RT Chlebowski M Tong J Weissman, et al. 1984 Hepatocellular carcinoma: diagnostic and prognostic features in North American patients Cancer 53 2701 2706 10.1002/1097-0142(19840615)53:12<2701::AID-CNCR2820531224>3.0.CO;2-B 1:STN:280:DyaL2c3gsFagsQ%3D%3D 6326991 (Pubitemid 14112905)
12. KE Stuart AJ Anand RL Jenkins 1996 Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival Cancer 77 2217 2222 10.1002/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M 1:STN:280:DyaK283isVyrtw%3D%3D 8635087 (Pubitemid 26162412)
13. DA Geller A Tsung J Wallis Marsh, et al. 2006 Outcome of 1000 liver cancer patients evaluated at the UPMC Liver Cancer Center J Gastrointest Surg 10 63 68 10.1016/j.gassur.2005.06.032 16368492 (Pubitemid 41820589)
14. JP Hwang MM Hassan 2009 Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation BMC Cancer 9 46 10.1186/1471-2407-9-46 19193234
15. GLH Wong VWS Wong GM Tan, et al. 2008 Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis Liver Int 28 1 79 87 1:CAS:528:DC%2BD1cXisl2rsLw%3D 17900247
16. BH Zhang BH Yang ZY Tang 2004 Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 130 417 422 15042359 (Pubitemid 39044345)
17. TSK Mok W Yeo S Yu, et al. 2005 An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results J Clin Oncol 23 31 8041 8047 10.1200/JCO.2005.01.9927 16258102 (Pubitemid 46657406)
18. THH Chen CJ Chen MF Yen, et al. 2002 Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan Int J Cancer 98 257 261 10.1002/ijc.10122 1:CAS:528:DC%2BD38XhsVSkuro%3D 11857416 (Pubitemid 34150810)
19. S Mima C Sekiya H Kanagawa, et al. 1994 Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan J Gastroenterol Hepatol 9 361 365 10.1111/j.1440-1746.1994.tb01256.x 1:STN:280:DyaK2M%2FjsF2gtQ%3D%3D 7524721 (Pubitemid 24227910)
20. H Toyoda T Kumada S Kiriyama, et al. 2006 Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan Clin Gastroenterol Hepatol 4 1170 1176 10.1016/j.cgh.2006.06.007 16890027 (Pubitemid 44311651)
21. PC Adams MJ Arthur TD Boyer, et al. 2004 Screening in liver disease: report of an AASLD clinical workshop Hepatology 39 1204 1212 10.1002/hep.20169 15122748 (Pubitemid 38569041)
22. M Schwartz 1961 A biomathematical approach to clinical tumor growth Cancer 14 1272 1294 10.1002/1097-0142(196111/12)14:6<1272::AID- CNCR2820140618>3.0.CO;2-H 1:STN:280:DyaF387gtFaqsA%3D%3D 13909709
23. HB El-Serag M Lau K Eschbach, et al. 2007 Epidemiology of hepatocellular carcinoma in Hispanics in the United States Arch Intern Med 167 18 1983 1989 10.1001/archinte.167.18.1983 17923599 (Pubitemid 47606639)
24. MJ Tong SC Sun BT Schaeffer, et al. 1971 Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan Ann Intern Med 75 687 691 1:STN:280:DyaE38%2FkslyhtQ%3D%3D 4330676
25. L Bolondi S Sofia S Siringo, et al. 2001 Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis Gut 48 251 259 10.1136/gut.48.2.251 1:STN:280:DC%2BD3M7is1WnsQ%3D%3D 11156649 (Pubitemid 32141852)
26. A Sangiovanni E Del Ninno P Fasani, et al. 2004 Increased survival of cirrhotic patients with a hepatocellular carcinoma during surveillance Gastroenterology 126 1005 1014 10.1053/j.gastro.2003.12.049 15057740 (Pubitemid 38451172)
27. F Trevisani G Magini V Santi, et al. 2007 Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance Am J Gastroenterol 102 1022 1031 10.1111/j.1572-0241.2007.01100.x 17313497 (Pubitemid 46698223)
28. S Pasqual J Irurzun P Zapater, et al. 2008 Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice Liver Int 28 5 682 689 (Pubitemid 351541101)
29. SJ Hwang MJ Tong PPC Lai, et al. 1996 Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America J Gastroenterol Hepatol 11 949 954 1:STN:280:DyaK2s%2FmvV2ntw%3D%3D 8912133
30. MJ Tong LM Blatt JH Kao, et al. 2006 Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma World J Gastroenterol 12 41 6620 6626 1:CAS:528:DC%2BD2sXntVahs7o%3D 17075974
31. MJ Tong LM Blatt JH Kao, et al. 2007 Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers Liver Int 27 10 1356 1363 1:CAS:528:DC%2BD1cXkvVGjtA%3D%3D 17900245
32. HI Yang SH Yeh PJ Chen, et al. 2008 Association between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma J Natl Cancer Inst 100 1134 1143 10.1093/jnci/djn243 1:CAS:528:DC%2BD1cXhtFKrsb7P 18695135
33. MF Yuen Y Tanaka DYT Fong, et al. 2009 Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B J Hepatol 50 80 88 10.1016/j.jhep.2008.07.023 18977053
34. M Sherman KM Peltekian C Lee 1995 Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population Hepatology 22 432 438 1:STN:280:DyaK2Mzmt1WltA%3D%3D 7543434
35. MJ Tong LM Blatt VWC Kao 2001 Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America J Gastroenterol Hepatol 16 553 559 10.1046/j.1440-1746.2001.02470.x 1:STN:280:DC%2BD3M3lt1KhtA%3D%3D 11350553 (Pubitemid 34188864)
36. L Barbara G Nemzi S Gaiani, et al. 1992 Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival Hepatology 16 132 137 10.1002/hep.1840160122 1:STN:280:DyaK38zhs1ClsA%3D%3D 1352268
37. K Kubota H Ina Y Okada, et al. 2003 Growth rate of primary single hepatocellular carcinoma: determine optimal screening interval with contrast enhanced computed tomography Digest Dis Sci 48 3 581 586 10.1023/A:1022505203786 12757173 (Pubitemid 36324168)
38. S Okada N Okazaki H Nose 1993 Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time Hepato-Gastroenterol 40 311 315 1:STN:280:DyaK2c%2FhtVKltQ%3D%3D (Pubitemid 23258545)
39. M Yoshino 1983 Growth kinetics of hepatocellular carcinoma Jpn J Clin Oncol 13 1 45 52 1:STN:280:DyaL3s7msVyhtA%3D%3D 6187947
40. JC Sheu JL Sung DS Chen, et al. 1985 Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications Gastroenterology 89 259 266 1:STN:280:DyaL2M3jtFyktQ%3D%3D 2408960 (Pubitemid 15028580)
41. F Farianati S Gianni 2001 Surveillance for hepatocellular carcinoma in cirrhosis: is it cost effective? Eur J Cancer Prev 10 111 115 10.1097/00008469-200102000-00017 (Pubitemid 32200213)
42. JP Duffy A Vardanian E Benjamin, et al. 2007 Liver transplantation criteria for hepatocellular carcinoma should be expanded Ann Surg 246 502 511 10.1097/SLA.0b013e318148c704 17717454 (Pubitemid 47312148)
43. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 5 1208 1236 10.1002/hep.20933 16250051 (Pubitemid 43112690)